New York, United States, July 19, 2022 (GLOBE NEWSWIRE) -- Plasmapheresis is a technique for returning blood cells and platelets to the donor's body immediately following a whole blood donation while keeping just the blood plasma. Pheresis, also known as apheresis, refers to any procedure that takes blood, filters, and returns the blood to the body. It is possible to separate platelets, red blood cells, white blood cells, or plasma. The treatment is carried out using a machine that extracts small volumes of blood.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/plasmapheresis-machines-market/request-sample
Technological Advancements to Drive the Demand for Plasmapheresis Machines
Continuous-flow centrifugation technology has been evolved as a high-precision method throughout the years. This has resulted in a significant improvement in patient comfort and efficiency in the processing of blood and plasma products. In contrast to other technologies such as membrane separation techniques, this method requires very little blood flow. It is also an improved technique that allows for simple access to blood through the patient's peripheral veins than previous membrane-based apheresis devices that need invasive central venous catheterization.
Furthermore, technical advancements result in increased patient convenience, safety, and quality care during TPE procedures and improved fluid balance management for hemodynamic stability throughout treatment. Such technological innovations for product enhancement are likely to fuel the overall market growth during the projected period.
Developing economies like India, China, Brazil, South Korea, and Mexico give colossal possibilities to add up to the expansion of both existing and new market members. This is fundamental because of consistent advances in the medical services framework, lower administrative obstacles, an increase in the target patient population, and a rising medical care budget. Contrasted with industrialized nations, administrative guidelines in the Asia-Pacific region are more versatile and business-accommodating.
Due to expanded rising competition in developed nations, organizations in the plasmapheresis machines market have moved their prominence in developing regions like India, China, and Japan. For instance, in April 2018, B. Braun, a German-based drug and clinical gadget business, opened five new offices in Penang, Malaysia, and in 2017, it laid out an establishment in Zambia. Moreover, the rising consciousness of immune system ailments and other blood-related diseases in emerging nations is projected to impact plasmapheresis machines, encouraging critical interest from here on out. All these factors contribute to the growth of the plasmapheresis machines market globally.
Report Scope
| Report Metric | Details |
| Market Size | USD in Billion by 2030 |
| CAGR | 8.56% (2022-2030) |
| Historical Data | 2019-2020 |
| Base Year | 2021 |
| Forecast Period | 2022-2030 |
| Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type, Application, End-User and Regions |
| Geographies Covered | North America, Europe, Asia-Pacific, LAME and Rest of the World |
| Key Companies Profiled/Vendors | Baxter International Inc., Fresenius Medical Care, Haemonetics Corporation, Terumo BCT Inc., Asahi Kasei, Medical Co. Ltd., Nikkiso, B Braun Melsungen AG |
| Key Market Opportunities | Emerging Markets to Provide Profitable Opportunities |
| Key Market Drivers | Increased Incidences of Chronic Diseases to Surge the Need for Plasmapheresis Machines The High Cost of Procedures to Restrict Plasmapheresis Machines Market Growth |
Buy Now Full Report @ https://straitsresearch.com/buy-now/plasmapheresis-machines-market
Impact of COVID-19
COVID-19 provoked the World Health Organization to announce an overall pandemic for the general well-being crisis in March 2020. The pandemic started in December 2019 in Wuhan, China, and immediately raised from a little fiasco to a worldwide pandemic. A few notable biopharmaceutical and drug organizations, independent companies, and new businesses have created viable treatments for Covid disease.
During the early stage of the pandemic, no specific drugs for their treatment had been approved. Then again, recuperating plasma (CP) treatment had been displayed to develop the endurance pace of COVID-19 patients, given positive outcomes from various clinical preliminaries. Subsequently, government experts in countries such as the United States and India have successfully given plasma treatments to COVID-19 patients. This increased the demand for plasmapheresis machines during this period.
Key Insights
- Based on type, the plasmapheresis machines market is segmented as a Plasma collection system and a multi-component collection system. The multi-component collection system acquired the highest market share in 2021 and is expected to grow at a CAGR of 9.0% by 2030.
- By application, the plasmapheresis machines market is divided into extracorporeal therapy, plasma donation. The extracorporeal therapy segment is expected to grow at an elevated CAGR of 9.20% by 2030.
- Geographically the market is segmented as North America, Europe, Asia-Pacific, the Middle East and Africa. North America and Europe are the two dominant markets for plasmapheresis machines.
- North America has acquired more than 50% of the market share in 2021 and is expected to grow at a CAGR of 8.90% by 2030.
- Europe acquired the second-largest market share in 2021 and is expected to grow at a CAGR of 8.85% during the forecast period.
Get a Free Sample Copy of This Report @ https://straitsresearch.com/report/plasmapheresis-machines-market/request-sample
List of Key Players
- A.T Cross Co.
- Caran D'ache
- Faber-Castell
- Grayson Tighe
- Hugo Boss
- Jack Row
- Montblanc
- Conklin Pens
- Fisher Space Pen
- Bentley Motors
- Bespoke British Pens Ltd.
Global Plasmapheresis Machines Market: Segmentation
By Type
- Plasma Collection System
- Multi-Component Collection System
By Application
- Extracorporeal Therapy
- Plasma Donation
By End-User
- Biopharmaceutical Companies
- Hospitals and Clinics
- Others
Regions Covered
- North America
- Europe
- Asia-Pacific
- The Middle East and Africa
TABLE OF CONTENT
1 Introduction
1.1 Market Definition
1.2 Market Scope
2 Research Methodology
2.1 Primary Research
2.2 Research Methodology
2.3 Assumptions & Exclusions
2.4 Secondary Data Sources
3 Executive Summary
4 Market Overview
4.1 Report Segmentation & Scope
4.2 Value Chain Analysis: Plasmapheresis Machines Market
4.2.1 Vendor Matrix
4.3 Key Market Trends
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.4 Porter’s Five Forces Analysis
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Environment & Regulatory Landscape
4.6 Forecast Factors & Relevance of Impact
4.7 Macro-Economic & Geopolitical Scenario
4.8 Parent Market Overview
4.9 Technology Landscape
4.10 Market Share Analysis
4.11 Potential Venture Analysis
4.12 Regional Price Trends
4.13 Raw Material Trends
4.14 Cost Structure Analysis
4.14.1 Labor Cost
4.14.2 Consumables
4.14.3 Maintenance Cost
4.15 Covid-19 Impact Analysis:
4.15.1 Pre and Post Covid-19 Market Scenario Analysis
4.15.2 Market Recovery Timeline and Challenge
4.15.3 Measures Taken by Top Players
4.15.4 Quarterly Market Revenue and Growth Forecast till 2021
4.15.4.1 North America
4.15.4.2 Europe
4.15.4.3 Asia-Pacific
4.15.4.4 Central and South America and the Caribbean
4.15.4.5 The Middle East and Africa
5 Type Overview
5.1 Introduction
5.1.1 Market Size & Forecast (Value & Volume)
5.2 Plasma Collection System
5.2.1 Market Size & Forecast (Value & Volume)
5.3 Multi-Component Collection System
5.3.1 Market Size & Forecast (Value & Volume)
6 Application Overview
6.1 Introduction
6.1.1 Market Size & Forecast (Value & Volume)
6.2 Extracorporeal Therapy
6.2.1 Market Size & Forecast (Value & Volume)
6.3 Plasma Donation
6.3.1 Market Size & Forecast (Value & Volume)
7 End User Overview
7.1 Introduction
7.1.1 Market Size & Forecast (Value & Volume)
7.2 Biopharmaceutical Companies
7.2.1 Market Size & Forecast (Value & Volume)
7.3 Hospitals and Clinics
7.3.1 Market Size & Forecast (Value & Volume)
7.4 Others
7.4.1 Market Size & Forecast (Value & Volume)
8 Regional Overview
8.1 Introduction
8.1.1 Market Size & Forecast (Value & Volume)
8.2 North America
8.2.1 Economic Overview
8.2.2 Market Scenario
8.2.3 U.S.
8.2.4 Canada
8.2.5 Mexico
8.3 Central and South America and the Caribbean
8.3.1 Economic Overview
8.3.2 Market Scenario
8.3.3 Brazil
8.3.4 Argentina
8.3.5 Colombia
8.3.6 Rest of Central and South America and the Caribbean
8.4 Europe
8.4.1 Economic Overview
8.4.2 Market Scenario
8.4.3 Germany
8.4.4 France
8.4.5 The U.K.
8.4.6 Italy
8.4.7 The Rest Of Europe
8.5 Asia-Pacific (APAC)
8.5.1 Economic Overview
8.5.2 Market Scenario
8.5.3 China
8.5.4 Japan
8.5.5 India
8.5.6 Australia
8.5.7 South Korea
8.5.8 Rest Of APAC
8.6 Middle East
8.6.1 Economic Overview
8.6.2 Market Scenario
8.6.3 South Arabia
8.6.4 The UAE
8.6.5 Qatar
8.6.6 Oman
8.6.7 Turkey
8.6.8 The Rest Of Middle East
8.7 Africa
8.7.1 Economic Overview
8.7.2 Market Scenario
8.7.3 Nigeria
8.7.4 South Africa
8.7.5 The Rest Of Africa
9 Competitive Landscape — Manufacturers & Suppliers
9.1 Competition Dashboard
9.2 Industry Structure
9.3 Baxter International Inc.
9.3.1 Business Overview
9.3.2 Financial Performance
9.3.3 Recent Developments
9.3.4 Portfolio
9.4 Fresenius Medical Care
9.5 Haemonetics Corporation
9.6 Terumo BCT Inc.
9.7 Asahi Kasei
9.8 Medical Co. Ltd.
9.9 Nikkiso
9.10 B Braun Melsungen AG
10 Conclusion & Recommendation
11 Acronyms & Abbreviations
Table of Content and Figure @ https://straitsresearch.com/report/plasmapheresis-machines-market/toc
Market News
- In April 2021, following the expiration of the current term in June 2022, CSL plasma Ltd. announced its intention not to extend its Supply Agreement with Haemonetics to use PCS2 plasma collection system equipment and purchase a disposable plasmapheresis kit in the United States.
- In October 2020, Nigale's plasma separator products were widely used when China started developing convalescent plasma to treat patients infected with COVID-19.
- In July 2017, Haemonetics Corporation received FDA 510(k) clearance for its NexSys PCS plasmapheresis system.
News Media
Coronavirus Crisis - Impact Of COVID-19 On Healthcare Industry
North America to Hold the Lion’s Share in the Plasma Therapy Market
Have a Look at the Related Research Report
Medical Refrigerators Market: Information by Type (Blood Bank Refrigerators and Plasma Freezers, Pharmacy Refrigerators and Freezers), End Use, and Region — Forecast till 2029
Gelatin Polypeptide Plasma Expanders Market: Information by Type (Polygeline, Succinylated Gelatine), Application (Perioperative), Sources of Gelatin (Bovine), and Region — Forecast till 2026
Colloids (Blood Plasma) Market: Information by Type (Natural Type Colloids and Synthetic Type Colloids) and Application (Extensive Burns, Massive Blood, Hypovolemic Shock)- Forecast Till 2026
mTPE Device Market: Information by Therapeutic Type (Bone Marrow, Renal Dialysis), Application (Cell Depletion, Granulocyte Collection), and End User, and Region — Forecast till 2029
Biological Safety Testing Products and Services Market: Information by Product (Test Kits and Reagents), Test (Endotoxin Test, Adventitious Agent), and Region — Forecast till 2029
About Straits Research Pvt. Ltd.
StraitsResearch is a market intelligence company providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision-makers. Straits Research Pvt. Ltd. provides actionable market research data, especially designed and presented for decision making and ROI.
Whether you are looking at business sectors in the next town or crosswise over continents, we understand the significance of being acquainted with the client’s purchase. We overcome our clients’ issues by recognizing and deciphering the target group and generating leads with utmost precision. We seek to collaborate with our clients to deliver a broad spectrum of results through a blend of market and business research approaches.
For more information on your target market, please contact us below:
Phone: +1 646 480 7505 (the U.S.)
+91 8087085354 (APAC)
+44 208 068 9665 (the U.K.)
Email: sales@straitsresearch.com
Follow Us: LinkedIn | Facebook | Instagram | Twitter
